FDA Joint Advisory Committee Allows GSK Avandia To Stay On Market
Posted by: DrugsNews on: 17 Jul, 2010
- In: Drugs Updates
- Comments Off
FDA Joint Advisory Committee Allows GSK Avandia To Stay On Market. FDA’s joint advisory committee has voted to allow GlaxoSmithKline’s (GSK) Avandia to remain on the market. The recommendations voted by the committee members range from making no changes to the current label, to revising the label with additional warnings and restrictions to withdrawal from [...]
